The story of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the healthcare sector. Although its early success and impact of vast in sales, the exclusivity end has opened the floodgates for generic medications, greatly reducing profit prospects . This transition raises doubts about the continu